作者: O.Kenneth Macdonald , Christopher H Crane
DOI: 10.1016/S1055-3207(02)00038-8
关键词:
摘要: Abstract Local failure is the primary limitation for cure in patients with BTC. whether or not they have been resected. The use of radiotherapy without chemotherapy postoperative setting controversial, but some studies reported improvement 5-year survival. In unresectable BTC, EBRT offers effective palliation symptomatic disease and has resulted improved median long-term survival a small number most studies. Novel approaches, including neoadjuvant chemoradiotherapy combined OLT, escalated conformal irradiation, seem to be promising warrant further investigation.